Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 7 | 2023 | 233 | 3.010 |
Why?
|
| Brain Ischemia | 3 | 2020 | 80 | 1.450 |
Why?
|
| Metabolomics | 3 | 2023 | 79 | 0.880 |
Why?
|
| Amino Acids | 2 | 2022 | 80 | 0.850 |
Why?
|
| Hydrocephalus | 1 | 2022 | 51 | 0.760 |
Why?
|
| Hyperglycemia | 1 | 2022 | 77 | 0.740 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 61 | 0.730 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 117 | 0.690 |
Why?
|
| Pilot Projects | 4 | 2023 | 390 | 0.680 |
Why?
|
| Brain | 2 | 2021 | 699 | 0.640 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 802 | 0.630 |
Why?
|
| Biomarkers | 6 | 2023 | 733 | 0.570 |
Why?
|
| Puerperal Disorders | 1 | 2011 | 14 | 0.380 |
Why?
|
| Humans | 15 | 2024 | 26846 | 0.370 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 472 | 0.360 |
Why?
|
| Pregnancy Complications | 1 | 2011 | 105 | 0.350 |
Why?
|
| Longitudinal Studies | 2 | 2023 | 400 | 0.350 |
Why?
|
| Retrospective Studies | 4 | 2022 | 2433 | 0.310 |
Why?
|
| Autonomic Dysreflexia | 1 | 2007 | 1 | 0.290 |
Why?
|
| Hypotension, Orthostatic | 1 | 2007 | 8 | 0.280 |
Why?
|
| Cerebral Hemorrhage | 2 | 2022 | 90 | 0.280 |
Why?
|
| Prospective Studies | 2 | 2020 | 1216 | 0.270 |
Why?
|
| Spinal Cord Injuries | 1 | 2007 | 55 | 0.270 |
Why?
|
| Autonomic Nervous System | 1 | 2007 | 110 | 0.260 |
Why?
|
| Prognosis | 4 | 2020 | 759 | 0.250 |
Why?
|
| Spinal Cord | 1 | 2007 | 202 | 0.240 |
Why?
|
| Acute Disease | 2 | 2020 | 153 | 0.240 |
Why?
|
| Cerebral Infarction | 2 | 2020 | 26 | 0.220 |
Why?
|
| Alanine | 1 | 2023 | 40 | 0.220 |
Why?
|
| Zebrafish | 1 | 2024 | 95 | 0.220 |
Why?
|
| Middle Aged | 8 | 2024 | 6820 | 0.210 |
Why?
|
| Blood Volume | 1 | 2022 | 8 | 0.200 |
Why?
|
| Sphingolipids | 1 | 2022 | 20 | 0.200 |
Why?
|
| Apolipoprotein C-III | 1 | 2021 | 12 | 0.190 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2021 | 36 | 0.190 |
Why?
|
| Infusions, Intravenous | 1 | 2021 | 99 | 0.190 |
Why?
|
| Thrombolytic Therapy | 1 | 2021 | 36 | 0.190 |
Why?
|
| Fibrinolytic Agents | 1 | 2021 | 67 | 0.180 |
Why?
|
| Brain Infarction | 1 | 2020 | 10 | 0.180 |
Why?
|
| Glucaric Acid | 1 | 2020 | 10 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 322 | 0.180 |
Why?
|
| Female | 9 | 2024 | 14466 | 0.180 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 346 | 0.180 |
Why?
|
| Genetic Variation | 1 | 2021 | 229 | 0.180 |
Why?
|
| Carotid Artery Thrombosis | 1 | 2019 | 4 | 0.170 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2019 | 16 | 0.170 |
Why?
|
| Diagnosis, Differential | 1 | 2021 | 367 | 0.170 |
Why?
|
| Thrombectomy | 1 | 2019 | 26 | 0.170 |
Why?
|
| Positron-Emission Tomography | 1 | 2020 | 98 | 0.170 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 26 | 0.170 |
Why?
|
| Male | 8 | 2024 | 12874 | 0.160 |
Why?
|
| Endovascular Procedures | 1 | 2019 | 60 | 0.160 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 213 | 0.160 |
Why?
|
| Chronic Disease | 1 | 2020 | 263 | 0.160 |
Why?
|
| Treatment Outcome | 3 | 2021 | 2264 | 0.160 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 207 | 0.140 |
Why?
|
| Platelet Count | 1 | 2017 | 112 | 0.140 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 54 | 0.140 |
Why?
|
| Aged | 6 | 2024 | 5168 | 0.140 |
Why?
|
| Tangier Disease | 1 | 2011 | 1 | 0.100 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2011 | 6 | 0.100 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 465 | 0.100 |
Why?
|
| Eclampsia | 1 | 2011 | 5 | 0.100 |
Why?
|
| Vasospasm, Intracranial | 1 | 2011 | 14 | 0.100 |
Why?
|
| Pre-Eclampsia | 1 | 2011 | 48 | 0.090 |
Why?
|
| Venous Thrombosis | 1 | 2011 | 98 | 0.090 |
Why?
|
| Adult | 4 | 2024 | 7384 | 0.080 |
Why?
|
| Animals | 3 | 2024 | 9962 | 0.080 |
Why?
|
| Infant, Newborn | 1 | 2011 | 844 | 0.080 |
Why?
|
| Pregnancy | 1 | 2011 | 1131 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2007 | 54 | 0.070 |
Why?
|
| Injury Severity Score | 1 | 2007 | 117 | 0.070 |
Why?
|
| Thoracic Vertebrae | 1 | 2007 | 66 | 0.070 |
Why?
|
| Cervical Vertebrae | 1 | 2007 | 112 | 0.060 |
Why?
|
| Prevalence | 1 | 2007 | 472 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2007 | 859 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2024 | 67 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 1928 | 0.060 |
Why?
|
| Biological Specimen Banks | 1 | 2023 | 8 | 0.060 |
Why?
|
| Mutation | 2 | 2021 | 820 | 0.050 |
Why?
|
| United Kingdom | 1 | 2023 | 70 | 0.050 |
Why?
|
| Spinal Stenosis | 1 | 2003 | 15 | 0.050 |
Why?
|
| Time Factors | 1 | 2007 | 1562 | 0.050 |
Why?
|
| Metabolome | 1 | 2023 | 64 | 0.050 |
Why?
|
| Blood Glucose | 1 | 2024 | 300 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 176 | 0.050 |
Why?
|
| Exosomes | 1 | 2024 | 92 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 8 | 0.050 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2024 | 544 | 0.050 |
Why?
|
| Heterozygote | 1 | 2021 | 64 | 0.050 |
Why?
|
| Europe | 1 | 2021 | 96 | 0.050 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 110 | 0.050 |
Why?
|
| Risk | 1 | 2021 | 133 | 0.050 |
Why?
|
| India | 1 | 2021 | 137 | 0.050 |
Why?
|
| Triglycerides | 1 | 2021 | 117 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 664 | 0.050 |
Why?
|
| Perfusion | 1 | 2020 | 43 | 0.050 |
Why?
|
| Alleles | 1 | 2021 | 347 | 0.050 |
Why?
|
| Genotype | 1 | 2021 | 443 | 0.040 |
Why?
|
| Necrosis | 1 | 2020 | 81 | 0.040 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2020 | 37 | 0.040 |
Why?
|
| Sequence Analysis, DNA | 1 | 2021 | 364 | 0.040 |
Why?
|
| Carotid Artery, Internal | 1 | 2019 | 19 | 0.040 |
Why?
|
| Adolescent | 1 | 2007 | 2957 | 0.040 |
Why?
|
| Middle Cerebral Artery | 1 | 2019 | 48 | 0.040 |
Why?
|
| Neutrophils | 1 | 2020 | 177 | 0.040 |
Why?
|
| Oxidation-Reduction | 1 | 2020 | 354 | 0.040 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 152 | 0.040 |
Why?
|
| Cytokines | 1 | 2020 | 439 | 0.040 |
Why?
|
| Sex Factors | 1 | 2019 | 445 | 0.040 |
Why?
|
| Age Factors | 1 | 2019 | 716 | 0.040 |
Why?
|
| Thrombosis | 1 | 2017 | 147 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 1394 | 0.030 |
Why?
|
| Algorithms | 1 | 2017 | 419 | 0.030 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2011 | 11 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 21 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2011 | 37 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 44 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 35 | 0.020 |
Why?
|
| Recurrence | 1 | 2011 | 316 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 2582 | 0.020 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2003 | 6 | 0.010 |
Why?
|
| Lumbosacral Region | 1 | 2003 | 20 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 2003 | 73 | 0.010 |
Why?
|